Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque Test
This study has been completed.
Study NCT00578370   Information provided by ISDIN
First Received: December 20, 2007   Last Updated: November 4, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Psoriasis
More general conditions related to this trial
Skin Diseases
Skin Diseases, Papulosquamous
Interventions listed in this trial
Ciclosporin 0.5% (Formulation 01B)
Ciclosporin 1.5% (Formulation 02B)
0.1% betamethasone
0.005% calcipotriol
Formulation 00B
Additional drug interventions recognized in this trial
Betamethasone
Betamethasone sodium phosphate
Betamethasone-17,21-dipropionate
Calcipotriene
Cyclosporine
Cyclosporins
More general drug interventions related to this trial
Anti-Asthmatic Agents
Anti-Infective Agents
Anti-Inflammatory Agents
Antifungal Agents
Antirheumatic Agents
Dermatologic Agents
Enzyme Inhibitors
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
ISDIN


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services